Cleared Traditional

CARDIOLINE HD+ (K150289) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K150289 · Cardioline S.P.A · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2015
Decision
203d
Days
Class 2
Risk

K150289 is an FDA 510(k) clearance for the CARDIOLINE HD+. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Cardioline S.P.A (Cavareno, US). The FDA issued a Cleared decision on August 27, 2015 after a review of 203 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardioline S.P.A devices

Submission Details

510(k) Number K150289 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 05, 2015
Decision Date August 27, 2015
Days to Decision 203 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
78d slower than avg
Panel avg: 125d · This submission: 203d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 58
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K150289.
BioStamp nPoint
K173510 · Mc10, Inc. · May 2018
Patient Status Engine
K172329 · Isansys Lifecare, Ltd. · Apr 2018
FFR Link, FFR Signal Processing Module
K170204 · Boston Scientific Corporation · Mar 2017
3M LITTMANN TELESTETH ONLINE AUSCULATION SYSTEM
K120704 · 3M Company · May 2012
3M LITTMANN SCOPE-TO SCOPE SOFTWARE SYSTEM
K101834 · 3M Company · Sep 2010
FORA GW 9014 TELEHEALTH GATEWAY/TD-9014 TELEHEALTH GATEWAY
K100427 · Taidoc Technology Corporation · May 2010